AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Respiratory Tract Infections: Moxifloxacin is commonly used to treat respiratory tract infections caused by susceptible bacteria. This includes:
Skin and Soft Tissue Infections: Moxifloxacin may be prescribed to treat skin and soft tissue infections caused by susceptible bacteria, including:
Intra-Abdominal Infections: Moxifloxacin can be used to treat intra-abdominal infections such as peritonitis and intra-abdominal abscesses.
Urinary Tract Infections (UTIs): Moxifloxacin is effective against UTIs caused by susceptible bacteria, including complicated and uncomplicated UTIs.
Sexually Transmitted Infections (STIs): Moxifloxacin may be used to treat certain STIs caused by susceptible bacteria, such as gonorrhea.
Eye Infections: Moxifloxacin eye drops are prescribed to treat bacterial conjunctivitis (pink eye) and corneal ulcers caused by susceptible organisms.
Safety Considerations: Moxifloxacin, like other fluoroquinolones, may be associated with side effects such as gastrointestinal disturbances (nausea, vomiting, diarrhea), headache, dizziness, and photosensitivity. Rare but serious adverse effects include tendonitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is essential to use moxifloxacin cautiously, especially in patients with a history of tendon disorders or myasthenia gravis.
Bacterial Resistance: Overuse or misuse of moxifloxacin can lead to the development of bacterial resistance, reducing its effectiveness in treating infections.
Interactions: Moxifloxacin may interact with other medications, including antacids containing magnesium or aluminum, sucralfate, and certain medications that prolong the QT interval. It is essential to inform your healthcare provider about all medications you are taking before starting moxifloxacin treatment.
Duration of Treatment: The duration of moxifloxacin treatment varies depending on the type and severity of the infection. It is crucial to complete the prescribed course of treatment as directed by your healthcare provider, even if symptoms improve before the medication is finished.
(actimoxiflox, advancrib, akamoxx, apdrops, apdrops dx, atafloks, avalox, avelox, avemox, biofloxacin, cinagen, delmoxa, dominal, eye-quin, flomox, flovacil, floxamic, floxitrat, floxsafe, fluroquinomox 0.5%, fortymox 0.5%, getmoxy, idelox, imix, mahaflox, megaxin, mevafast, mofelox, mofinacin, moflox, mofloxin lafrancol, mograflox 0.5%, moksacin, moksefen, moksifloksacin alvogen, moksifloksacin pharmas, moloxin, monafox, morris, mosi, mosi-d, moxacin, moxai, moxavidex, moxday, moxi, moxibact, moxicip, moxicum, moxieye, moxifloksacin lek, moxiflox, moxifloxacin actavis, moxifloxacin aurobindo, moxifloxacin kabi, moxifloxacin ratiopharm, moxifloxacin sabaa, moxifloxacina aurobindo, moxifloxacina la santΓ©, moxifloxacine teva, moxifloxacin-mepha, moxifloxacino ratiopharm, moxifloxacino tevagen, moxifloxacin-ratiopharm, moxifor, moxigram, moxiquin, moxital, moxitec, moxitrix, moxivin, moxof, moxoft, oftamox, oftamox d, omnimox, pitoxil, pitoxil-sanovel, plivamox, quinomax, raspelocin, rowamoxiflox, staxom, unomox, vigadexa, vigamox, vigamox 0.5%, xiflodrop, actira, avebact, avelon, cenomar, cimocinox, drl moxifloxacin, eyemox, flamix, floromox, iventi, izilox, kanavig, lamoflox, lifodrox, litares, maxiflox, mikrobiel, mofil, moflag, moflag d, moflaxa, moflodal, moxaval, moxeza, moxflodel, moxibay, moxicino, moxiflo, moxifloxacin - 1 a pharma, moxifloxacin 1a pharma, moxifloxacin abz, moxifloxacin al, moxifloxacin apotex, moxifloxacin fresenius kabi, moxifloxacin heumann, moxifloxacin hexal, moxifloxacin krka, moxifloxacin noridem, moxifloxacin rivopharm, moxifloxacin sandoz, moxifloxacin spirig hc, moxifloxacin stada, moxifloxacin tad, moxifloxacin teva, moxifloxacina mk, moxifloxacin-actavis, moxifloxacine double-e pharma, moxifloxacine eg, moxifloxacine fresenius kabi, moxifloxacine krka, moxifloxacine mylan, moxifloxacine pch, moxifloxacine sandoz, moxifloxacino actavis, moxifloxacino apotex, moxifloxacino aurobindo, moxifloxacino cinfa, moxifloxacino kern pharma, moxifloxacino krka, moxifloxacino mylan, moxifloxacino qualigen, moxifloxacino sandoz, moxifloxacino stada, moxifloxacino zentiva, moxiforce, moxikacin, moxis, moxista, moxi-tech, moxivig, moxivig 0.5%, moxquin, numoxx, octegra, optimox, praxinstad, quinomed dx, rucela, vegamox 0.5%)
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium animalis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Bifidobacterium pseudocatenulatum | Reduces |
species | Bifidobacterium pseudolongum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
3 | 0 | Bacteroides fragilis | species | Decreases |
2 | 2 | Clostridium | genus | Decreases |
2 | 2 | Clostridium perfringens | species | Decreases |
2 | 1 | Phocaeicola vulgatus | species | Decreases |
2 | 1 | Bacteroides ovatus | species | Decreases |
2 | 1 | Bacteroides uniformis | species | Decreases |
2 | 1 | Bacteroides xylanisolvens | species | Decreases |
2 | 1 | Bacteroides thetaiotaomicron | species | Decreases |
2 | 1 | Bacteroides caccae | species | Decreases |
2 | 0 | Agathobacter rectalis | species | Decreases |
2 | 0 | Coprococcus comes | species | Decreases |
2 | 0 | Enterocloster bolteae | species | Decreases |
2 | 0 | Escherichia coli | species | Decreases |
2 | 0 | Roseburia intestinalis | species | Decreases |
2 | 0 | Segatella copri | species | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.7 | 0.7 | |
Acne | 3.1 | 1.3 | 1.38 |
ADHD | 6.6 | 1.1 | 5 |
Age-Related Macular Degeneration and Glaucoma | 1.1 | 0.4 | 1.75 |
Allergic Rhinitis (Hay Fever) | 5.4 | 4.3 | 0.26 |
Allergies | 10.6 | 5.3 | 1 |
Allergy to milk products | 2.5 | 2.3 | 0.09 |
Alopecia (Hair Loss) | 2.4 | 2.4 | |
Alzheimer's disease | 8.2 | 10 | -0.22 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 3.3 | 0.9 | 2.67 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]